Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Abionyx Pharma News

    0,957 € -1,44% -0,014 €
    08:05:37 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A14QR9
    ISIN: FR0012616852
    Typ: Aktie

    Abionyx Pharma News

    10.04.24 - Businesswire
    ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
    Regulatory News:
    14.03.24 - Businesswire
    ABIONYX Pharma - Bpifrance Supports the Development of CER-001 in Ophthalmology With a Nearly €1 Million Non-dilutive Innovation Grant
    Regulatory News:
    11.03.24 - Businesswire
    ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
    Regulatory News:
    11.03.24 - Businesswire
    ABIONYX Pharma Announces Its 2023 Full-Year Financial Results
    Regulatory News:
    07.03.24 - Businesswire
    ABIONYX Pharma announces its financial calendar for the year 2024
    Regulatory News:
    29.02.24 - Businesswire
    ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 4th Quarter 2023
    Regulatory News:
    16.02.24 - Businesswire
    ABIONYX Pharma: Clarification About Clinical Results From the Phase 3 of apoA-I study, CSL112
    Regulatory News:
    15.02.24 - Businesswire
    ABIONYX Pharma Acknowledges the Clinical Results of the Phase 3 AEGIS-II Study Evaluating the Efficacy and Safety of CSL Behring’s Human-plasma-derived apoA-I, CSL112
    Access here the full press release
    15.02.24 - Businesswire
    ABIONYX Pharma Acknowledges the Clinical Results of the Phase 3 AEGIS-II Study Evaluating the Efficacy and Safety of CSL Behring’s Human-plasma-derived apoA-I, CSL112
    Regulatory News:
    06.02.24 - Businesswire
    ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
    Regulatory News:

    Newssuche

    Videos

    newspaper
    09:30 Uhr +53,66%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »